Progress in Mind Portugal Your Psychiatry & Neurology Resource Center COVID-19 Learn more ECNP 21 Learn more Medical education resource center Do you want to learn more? Medical education resource center The Lundbeck Institute Campus – the medical education resource center in psychiatry and neurology. Learn More THINC® Focus on cognitive symptoms in depression See More Recent News AllDepressionMigraineSchizophrenia Depression 12 May, 2023 Read Time: 1 min Product Interview Que experiência têm os profissionais de saúde com a utilização da dose de 20 mg de Brintellix® para tratar os seus doentes com TDM? Saiba mais sobre a experiência do Professor Andrea Fagiolini com a dose de 20 mg no webinar que se... Depression 30 Oct, 2022 Read Time: 3 mins Congress highlights Article Highlights in depression research from APA Online 2022 Recent research findings in depression from the poster session at APA Online 2022 covered topics... Depression, Schizophrenia 18 Oct, 2022 Read Time: 5 mins Article Strategies for precision prescribing in psychiatry In a symposium at CINP 2022 entitled ‘Strategies for Precision Prescribing in Psychiatry,’ Prof... Mental Health 04 Oct, 2022 Read Time: 4 mins Congress highlights Article Benefits of measurement-based care in psychiatry Dr Erik Vanderlip (Oregon Health & Science University, USA) was involved in forming the Workgroup... Alzheimer's Disease, Parkinson's Disease 20 Sep, 2022 Read Time: 3 mins Congress highlights Article Will artificial intelligence replace or augment physicians? Artificial intelligence (AI) is already disrupting healthcare in many areas. Will it eventually... Migraine 19 Sep, 2022 Read Time: 3 mins Satellite symposium Article Assessing patient disability is vital for successful treatment of migraine When measuring the success of migraine treatment, it is easy to focus on clinical features like... Migraine 15 Sep, 2022 Read Time: 3 mins Satellite symposium Article Anti-CGRP monoclonal antibody therapy for migraine prevention in the real world Long-term clinical studies and real-world evidence are providing supportive data on the efficacy,... Migraine 14 Sep, 2022 How migraine can impact a person’s life when they are experiencing a migraine attack Professor Cristina Tassorelli sat down with us at EAN 2022 to introduce herself and discuss how... Migraine 13 Sep, 2022 Read Time: 5 mins Satellite symposium Article Experts’ perspectives on managing chronic migraine in their own clinical practice Three experts from different countries provided perspectives on their own clinical practice managing... Migraine 12 Sep, 2022 Read Time: 3 mins Congress highlights Article Raising the healthcare prioritization of headache: Why and how? Headache is the most common neurologic disorder but the least acknowledged, said Professor Rigmor... Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 … Next page › Last page » Depression 12 May, 2023 Read Time: 1 min Product Interview Que experiência têm os profissionais de saúde com a utilização da dose de 20 mg de Brintellix® para tratar os seus doentes com TDM? Saiba mais sobre a experiência do Professor Andrea Fagiolini com a dose de 20 mg no webinar que se... Depression 30 Oct, 2022 Read Time: 3 mins Congress highlights Article Highlights in depression research from APA Online 2022 Recent research findings in depression from the poster session at APA Online 2022 covered topics... Depression, Schizophrenia 18 Oct, 2022 Read Time: 5 mins Article Strategies for precision prescribing in psychiatry In a symposium at CINP 2022 entitled ‘Strategies for Precision Prescribing in Psychiatry,’ Prof... Mental Health 04 Oct, 2022 Read Time: 4 mins Congress highlights Article Benefits of measurement-based care in psychiatry Dr Erik Vanderlip (Oregon Health & Science University, USA) was involved in forming the Workgroup... Mental Health 24 Aug, 2022 Read Time: 3 mins Congress highlights Article How do psychiatric comorbidities affect migraine and its treatment? Patients with migraine often have psychiatric comorbidities. This can affect disease severity and... Depression 07 Mar, 2022 Read Time: 3 mins Satellite symposium What’s happening in the brain in major depressive disorder? Many different combinations of symptoms lead to a diagnosis of depression, and the many different... Mental Health 03 Mar, 2022 Read Time: 3 mins Congress highlights Current practice with e-mental health and future standards E-mental health is the future for improved mental health delivery at all stages of the patient... PTSD, Depression 28 Feb, 2022 Read Time: 3 mins Congress highlights Where and how are fear memories stored in the brain? When we experience fear, what happens to the memory of the fear in our brain? What happens in our... Depression 10 Feb, 2022 Read Time: 4 mins Satellite symposium The metabolic interplay between motivation, anxiety and depression There are major differences in individuals’ motivated behaviour and stress coping responses. Genetic... Depression, Schizophrenia 02 Dec, 2021 Read Time: 5 mins Satellite symposium Exploring life engagement in major depressive disorder (MDD) and schizophrenia – mechanisms, measurement, and meaning Functional recovery is a key goal in treatment of major depressive disorder and schizophrenia. In an... Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 … Next page › Last page » Migraine 19 Sep, 2022 Read Time: 3 mins Satellite symposium Article Assessing patient disability is vital for successful treatment of migraine When measuring the success of migraine treatment, it is easy to focus on clinical features like... Migraine 15 Sep, 2022 Read Time: 3 mins Satellite symposium Article Anti-CGRP monoclonal antibody therapy for migraine prevention in the real world Long-term clinical studies and real-world evidence are providing supportive data on the efficacy,... Migraine 14 Sep, 2022 How migraine can impact a person’s life when they are experiencing a migraine attack Professor Cristina Tassorelli sat down with us at EAN 2022 to introduce herself and discuss how... Migraine 13 Sep, 2022 Read Time: 5 mins Satellite symposium Article Experts’ perspectives on managing chronic migraine in their own clinical practice Three experts from different countries provided perspectives on their own clinical practice managing... Migraine 12 Sep, 2022 Read Time: 3 mins Congress highlights Article Raising the healthcare prioritization of headache: Why and how? Headache is the most common neurologic disorder but the least acknowledged, said Professor Rigmor... Migraine 12 Sep, 2022 Read Time: 4 mins Satellite symposium Article New real-world data on the use of calcitonin gene-related peptide monoclonal antibodies for migraine prevention New real-world data on the effectiveness, tolerability, and other benefits of migraine prevention... Migraine 30 Aug, 2022 Read Time: 3 mins Satellite symposium Article What can be done to lower the economic cost of migraine? The annual economic cost of migraine is high — estimated to be €50–111 billion in Europe in 2011.... Mental Health 24 Aug, 2022 Read Time: 3 mins Congress highlights Article How do psychiatric comorbidities affect migraine and its treatment? Patients with migraine often have psychiatric comorbidities. This can affect disease severity and... Migraine 21 Jul, 2022 Read Time: 3 mins Congress highlights Article Migraine research poster highlights from AAN Virtual 2022 Highlights of latest migraine research from the AAN Virtual 2022 poster session included use of... Migraine 18 Jul, 2022 Read Time: 6 mins Satellite symposium Article How to address the full impact of migraine In this symposium held at the 8th Congress of the European Academy of Neurology, Vienna, June 24−28... Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 … Next page › Last page » Depression, Schizophrenia 18 Oct, 2022 Read Time: 5 mins Article Strategies for precision prescribing in psychiatry In a symposium at CINP 2022 entitled ‘Strategies for Precision Prescribing in Psychiatry,’ Prof... Mental Health 04 Oct, 2022 Read Time: 4 mins Congress highlights Article Benefits of measurement-based care in psychiatry Dr Erik Vanderlip (Oregon Health & Science University, USA) was involved in forming the Workgroup... Schizophrenia 07 Sep, 2022 Read Time: 3 mins Congress highlights Article Interventions to improve real-life functioning Accurate assessment of neurocognition and social cognition and personalized cognitive training and... Schizophrenia 25 May, 2022 Read Time: 3 mins Congress highlights What is happening in the brain during schizophrenia? Neuroimaging reveals loss of brain gray matter volume in schizophrenia. New insights into the... Mental Health 03 Mar, 2022 Read Time: 3 mins Congress highlights Current practice with e-mental health and future standards E-mental health is the future for improved mental health delivery at all stages of the patient... Schizophrenia 18 Feb, 2022 Read Time: 3 mins Congress highlights Article New 2021 guidelines for the treatment of schizophrenia are now available in Japan The new evidence-based guidelines for the pharmacological therapy of schizophrenia from the Japanese... Schizophrenia 14 Feb, 2022 Read Time: 2 mins Congress highlights Can we predict the future of patients with early-episode psychosis? The ability to better predict patient outcomes would be highly valuable to clinicians, allowing the... Schizophrenia 08 Feb, 2022 Read Time: 4 mins Satellite symposium Long-acting therapies could reduce schizophrenia relapse Relapse in schizophrenia contributes to a downward spiral in disease progression. The likelihood of... Schizophrenia 06 Dec, 2021 Read Time: 4 mins Satellite symposium The COVID-19 pandemic and mental health - impact and implications One of the goals of the European College of Neuropsychopharmacology (ECNP) is to facilitate the... Depression, Schizophrenia 02 Dec, 2021 Read Time: 5 mins Satellite symposium Exploring life engagement in major depressive disorder (MDD) and schizophrenia – mechanisms, measurement, and meaning Functional recovery is a key goal in treatment of major depressive disorder and schizophrenia. In an... Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 … Next page › Last page » Most Popular Depression 12 May, 2023 Que experiência têm os profissionais de saúde com a utilização da dose de 20 mg de Brintellix® para tratar os seus doentes com TDM?